Skip to main content

Mogamulizumab achieves objective responses in relapsed/refractory adult T-cell leukemia-lymphoma

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Mogamulizumab achieves objective responses in relapsed/refractory adult T-cell leukemia-lymphoma

User login

Username

Password

Reset your password

Type	Lead	score